Investors & Strategic Partners

Foravisét welcomes discussions with investors and pharmaceutical partners interested in advancing a differentiated, non-hormonal approach to endometriosis.

We are pursuing financing and strategic opportunities spanning clinical readiness and Phase IIa proof of concept. Investment structures and participation can be discussed directly with our leadership team.

Investor materials and supporting scientific documentation are available upon request.

Jacob (J.J.) Marx
Co-Founder & CEO